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Abstract
Introduction: Private sector healthcare delivery in low- and middle-income countries is sometimes argued to be more
efficient, accountable, and sustainable than public sector delivery. Conversely, the public sector is often regarded as
providing more equitable and evidence-based care. We performed a systematic review of research studies investigating the
performance of private and public sector delivery in low- and middle-income countries.
Methods and Findings: Peer-reviewed studies including case studies, meta-analyses, reviews, and case-control analyses, as
well as reports published by non-governmental organizations and international agencies, were systematically collected
through large database searches, filtered through methodological inclusion criteria, and organized into six World Health
Organization health system themes: accessibility and responsiveness; quality; outcomes; accountability, transparency, and
regulation; fairness and equity; and efficiency. Of 1,178 potentially relevant unique citations, data were obtained from 102
articles describing studies conducted in low- and middle-income countries. Comparative cohort and cross-sectional studies
suggested that providers in the private sector more frequently violated medical standards of practice and had poorer
patient outcomes, but had greater reported timeliness and hospitality to patients. Reported efficiency tended to be lower in
the private than in the public sector, resulting in part from perverse incentives for unnecessary testing and treatment. Public
sector services experienced more limited availability of equipment, medications, and trained healthcare workers. When the
definition of ‘‘private sector’’ included unlicensed and uncertified providers such as drug shop owners, most patients
appeared to access care in the private sector; however, when unlicensed healthcare providers were excluded from the
analysis, the majority of people accessed public sector care. ‘‘Competitive dynamics’’ for funding appeared between the two
sectors, such that public funds and personnel were redirected to private sector development, followed by reductions in
public sector service budgets and staff.
Conclusions: Studies evaluated in this systematic review do not support the claim that the private sector is usually more
efficient, accountable, or medically effective than the public sector; however, the public sector appears frequently to lack
timeliness and hospitality towards patients.
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One longstanding and polarized debate in global health
concerns the appropriate role and balance of the public and
private sector in providing healthcare services to populations in
low- and middle-income countries [1]. In recent years, disputes
between the proponents of private and public systems have
become particularly heated, as the global economic recession that
began in 2007 has placed major constraints on government
budgets—the major funding source for healthcare expenditures in
most countries (Figure 1) [2]. The International Monetary Fund
has recommended that countries increase the scope of private
sector provision in health care as part of loan conditions [3], often
to reduce government debt [4]. Criticizing such efforts, the
international nonprofit organization Oxfam, in its report ‘‘Blind
Optimism,’’ concluded that ‘‘to achieve universal and equitable
access to health care, the public sector must be made to work as
the majority provider’’ [5]. The World Bank responded that it
seeks ‘‘more pragmatic approaches that build on what is available’’
by engaging with the private sector in countries where public
sector services perform poorly [6]; the Center for Global
Development similarly argued that the Oxfam report ‘‘ignored
the informal sector,’’ and that poor people ‘‘want to go’’ to private
providers and will ‘‘persist in doing so’’ [7].
Generally, this debate has been divided between those seeking
universal state-based healthcare availability and those advocating
for the private sector to provide care in areas where the public
sector has typically failed. Private sector advocates have pointed to
evidence that the ‘‘private sector is the main provider,’’ as many
impoverished patients prefer to seek care at private clinics [1].
They have suggested that the private sector may be more efficient
and responsive to patient needs because of market competition,
which they indicate should overcome government inefficiency and
corruption [8]. In contrast, public sector advocates have
highlighted inequities in access to health care resulting from the
inability of the poor to pay for private services. They have noted
that private markets often fail to deliver public health goods
including preventative services (a ‘‘market failure’’), and lack
coordinated planning with public health systems, required to curb
epidemics.
Both sides claim their critics are ‘‘ideologically biased’’ [9,10]
and selectively draw on case reports to defend their viewpoints
[5,7]. However, significant conflicts of interest may apply to both
groups [11], as large private international contractors, insurance
firms, and non-governmental organizations may benefit from
expanding the role of the private sector, while academics who rely
on state-funded grant proposals may gain resources from a greater
public sector role.
Crucially needed to inform this debate is a systematic review of
existing evidence. As Hanson and colleagues note, ‘‘A strengthened
evidence base on the performance of the public and private health
sectors is essential to guide decision-makers towards policy choices
that are appropriate for their contexts’’ [11]. However, in practice,
studies comparing the performance of private and public sectors are
difficult to implement, for several reasons. First, healthcare services
are not universally dichotomized between public and private
providers, as some practitioners participate in both state-based
and privately owned healthcare delivery systems, and many systems
are dually funded or informal. A wide range of arrangements exist
for how such expenditures are spent in public versus private clinics,
hospitals, and informal settings (see Box 1 for definitions). One
example of this complication is the role of informal payments in
Figure 1. General government expenditure on health as percent of total expenditure on health, 2008. n=190 countries for which data
are available. Source: [114].
doi:10.1371/journal.pmed.1001244.g001
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simplistic comparison between private and public systems. Second,
state-basedhealthcare servicesandprivateserviceshavecoexistedin
manylow- and middle-incomecountriesfordecades;most countries
have a large fraction (but not all) of healthcare expenditures paid for
bythestate,with most oftheremainderpaid forbyhouseholds[12].
In this context, simply defining what is private or public is not
straightforward. Private providers are heterogeneous, consisting of
formal for-profit entities such as independent hospitals, informal
entities that may include unlicensed providers, and nonprofit and
non-governmental organizations.
Although these debates have been highly visible, there is a
dearth of reviews on the topic. An initial search of prior systematic
reviews and meta-analyses in the PubMed database revealed one
recent review, evaluating 80 field-based studies that directly and
simultaneously compared service quality in ambulatory public and
private care clinics [1]. The analysis found that private outpatient
clinics often had better drug supplies and responsiveness than
public clinics, but the analysis did not assess other dimensions of
health system performance (such as accessibility). The review
excluded studies of hospitals, case reports, intervention studies
(such as how a sector responded to quality improvement
programs), or statistical studies of population-level data.
The aim of the current study is to evaluate available data on
public and private sector performance across the key domains of
health systems competencies. Our goal is to understand how the
private or public nature of a given healthcare delivery institution
may impact core healthcare delivery goals. We systematically
review published data and studies of private and public sector
performance in low- and middle-income countries against six
health systems themes used by World Health Organization
(WHO), adapted from the 2000 World Health Report [13]. The
six themes are as follows: accessibility and responsiveness; quality;
outcomes; accountability, transparency, and regulation; fairness
and equity; and efficiency [13] (Table 1).
Methods
Search Strategy
We searched for primary literature in eight major databases
using the indexed and free-text terms ‘‘private sector,’’ ‘‘privat-
ization,’’ ‘‘public-private sector partnerships,’’ and ‘‘public sector’’
in various combinations, as described in Text S1. Because much of
the discussion and data collection on this topic has been performed
outside of academic circles by international agencies and non-
governmental groups, we supplemented the database search by
conducting the same keyword searches on the websites of the
WHO library database WHOLIS, the World Bank Documents
and Reports repository, the United Nations Children’s Fund, the
United Nations Development Program, the Bill & Melinda Gates
Foundation, the Global Fund to Fight AIDS, Tuberculosis and
Malaria, Oxfam International, and the Kaiser Family Foundation
Global Health Division. The search terms included studies in
English, French, Italian, Spanish, Portuguese, or Russian,
published from 1 January 1980 through 31 August 2011.
Study Selection
All titles and abstracts found by the search strategy were filtered
for relevance to the study objective. Studies must have included
data on a population in at least one low- or middle-income
country, defined by the 2010 World Bank criteria of having
current per-capita gross national income less than or equal to
US$12,275 [14]. The full texts of potentially relevant articles were
subject to the inclusion criteria listed in Table 2 to ensure they met
basic minimum methodological standards. Qualitative studies
were included if they specified a systematic methodology for
interviews, focus group analysis, historical or political science
analysis, or ethnographic observation (see Text S2 for the
PRISMA checklist).
Data Extraction and Analysis
A data extraction method was designed by three reviewers (S.
B., J. A., and D. S.). J. A. extracted the data using a preestablished
standard data entry format into a database, with verification by S.
B. to ensure consistency of coding. Standard data describing each
study were also extracted, including the country where the study
was performed, study period, study methodology, number of
included participants, primary and secondary outcome measures
and end points, and study limitations. Where disclosed, we noted
the study funders and agencies. Disagreements between the two
reviewers were resolved by consensus among all authors.
The data synthesis was structured into six themes from the
updated WHO framework for health system assessment (see
Table 1 for themes, subthemes, and indicators used to assess each
theme) [13]. Relevant data that did not fall into one of these
themes was separately included in the analysis in an ‘‘other
factors’’ category that is discussed following the principal results.
Reports containing information relevant to more than one theme
were included in all related thematic areas. We did not perform
further subanalysis of the highest quality studies as the authors
could not agree to a vote-counting approach that would apply
across the quantitative and qualitative methods and the six WHO
themes captured in literature using different types of outcome
variables.
Results
The study selection process is shown in Figure 2 as a PRISMA
flow diagram. Of the 1,178 potentially relevant unique citations
from all literature searches, 102 studies met the inclusion criteria.
Box 1. Different Public and Private Healthcare
Delivery Agents in Low- and Middle-Income
Countries
Multinational and national for-profit corporations:
for-profit group practices, sometimes associated with
hospitals.
Formal individual private providers: individual phy-
sicians or other healthcare providers operating in smaller
scale healthcare facilities or private pharmacies.
Informal for-profit providers: unlicensed, unregulated
providers including shop owners, ‘‘injectors,’’ traditional
healers, and birth attendants.
Not-for-profit providers: civil society, non-governmen-
tal, and faith-based groups, charities; and community and
social enterprises, with varying degrees of regulation and
oversight.
Public hospitals, health centers, and clinics: county-
and district-level hospitals and clinics, with varying
degrees of accessibility and user fees for patients, often
having providers that also participate in private sector
healthcare delivery.
Public–private partnerships: International or national
associations that have varying degrees of for-profit or
nonprofit status, or collaborations between for-profit and
government/nonprofit entities to deliver services. Also
have varying user fees for patients and varying levels of
public subsidization for delivering healthcare services.
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Table 3. Fifty-nine studies were empirical research studies and 13
involved meta-analysis, with the rest involving case reports or
reviews. One-third of studies were carried out in the WHO-
defined African region (n=32) and another third in the Southeast
Asian region (n=34); most were published after 1990. We found
that about nine out of ten studies directly compared quality of care
in public versus private systems or assessed the demand for or
utilization of services; the remaining studies examined drug
availability or affordability or compared the cost and efficiency
of services.
Theme 1. Accessibility and Responsiveness
Six articles documented that a significant proportion of
outpatient services in low- and middle-income countries appeared
to be provided by the private sector [15–18]. However, the
percentage of total visits varied substantially across countries and
income levels [15]. In Viet Nam, the private sector provides 60%
of all outpatient contacts. In India, more than 90% of children
affected by diarrhea are taken to private healthcare providers, but
the income gradient was not specified among studies reporting this
data [17]. Among participants surveyed for HIV testing in 12
African countries, the proportion of patients using the private
sector for testing ranged from 3% to 45% [19].
Several studies disaggregated utilization by income levels,
tending to find that the private sector predominantly serves more
affluent populations. A widely cited study on access of the private
and public sectors was performed by the World Bank in 22 low-
and middle-income countries using Demographic and Health
Surveys [20]. Although interpretation of the findings varies [5,20],
the analysis found that in 19 of the countries studied, both wealthy
and poor families received more care from the private than the
public sector, but only when the private sector included private
drug shops and similar informal providers [21]; when the
composition of the private sector was limited to only licensed
and certified healthcare personnel, the public sector provided the
majority of care in low- and middle-income countries. However,
there were three exceptions: Namibia, Tanzania, and Zambia,
Table 1. WHO health system themes: data organization categories, subcategories, and indicators used.
System Evaluation Category Subcategory Description and Indicators
Access and responsiveness Availability Distance to facility and hours of service availability
Timeliness of service Waiting times from presentation to initial evaluation and
subsequent testing, results, and follow-up
Hospitality Patient questionnaire responses regarding treatment of
patients by the provider, and patient experiences when
navigating the health system
Quality Comprehensiveness of services Availability of all components of WHO package of
services
Diagnostic accuracy Rates of correct diagnosis on retrospective review
Management standards Rate of conformity to international disease-specific
management standards
Client retention Rate of loss to follow-up or, alternatively, rate of
appropriate patient return
Outcomes Treatment success rates Rate of therapy success, controlling for population
characteristics and delayed presentation
Population coverage Proportion of catchment population reached by
dedicated campaigns (e.g., vaccination rates)
Morbidity Rate of disability to patients, controlling for population
characteristics
Mortality Rate of death among patients, controlling for population
characteristics
Accountability, transparency, and regulation Data accessibility and quality Availability of data and appropriate use of indicators and
statistics
Public health functions Contribution of healthcare system to core public health
system functions (e.g., reporting of key diseases,
preventative care)
Reform capacity Results of quality improvement initiatives
Fairness and equity Financial barriers to care User fees, under-the-table charges, and pharmaceutical
costs
Distributive justice Healthcare availability commensurate with need
Efficiency Cost Absolute dollars spent for a given indication
Redundancy Repetition of diagnostic time, testing, supply chains, and
therapy delivery
Fragmentation Separation of core healthcare system functions,
generating sluggish management
Delays Time between ordering of tests or therapies and
execution of tests and therapies
doi:10.1371/journal.pmed.1001244.t001
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licensed personnel are counted. The percentage of visits to the
private sector was lower among the poor than among the wealthy
in these surveys, but the difference was not statistically significant.
Additionally, in Colombo, Sri Lanka, where the private sector
provided more than a quarter of all childhood immunizations
overall, among the wealthiest quartile it provided 72% of
immunizations but among the poorest quartile it provided only
3% [16]. In Uganda, 17.4% of women use private clinics or
midwives for their family-planning-related medical care due to
short distances and low transport costs, according to interviews
conducted among 10,706 women, of whom 57% were in the
country’s lowest wealth quintile [18].
Few studies have investigated ‘‘accessibility’’ per se (i.e., the
ability to access available services). However, wait times were
consistently found to be shorter in private sector than in public
sector facilities [22,23]. One interview-based study in Ghana
suggested that waiting times among public sector facilities could be
longer for the same condition than private sector facilities by one
or two hours [22]. Women living in rural Nigeria also reported
preferring private obstetric services to public services because
doctors were more frequently present at the time of patient
presentation [23].
Patients tended to report worse hospitality from providers at
public than private facilities (13 studies) [24–36]. In Bangladesh,
for example, public providers ranked lower than private providers
on scale-based surveys in which patients assessed the diagnostic
explanation given them, courtesy of staff, cleanliness of facilities,
capacity building, and the availability of certain medical inputs
[36]. A study in India found that patients were seen for longer
durations, were more likely to have a physical exam during their
visit, and were more likely to have their diagnosis explained to
them by private sector physicians than public sector ones [33].
Analysis in several countries suggested that patients in private
sector facilities reported preferring the facilities because of shorter
waiting periods, longer or more flexible opening hours, and better
availability of staff [34].
Theme 2. Quality of Health Care
Nine retrospective chart reviews and survey-based studies found
that diagnostic accuracy and adherence to medical management
standards were worse among private than public sector care
providers [37–45]. Most of these studies examined infectious
disease management protocols, including for tuberculosis and
malaria [46]. Private practitioners had significantly worse knowl-
edge of correct diagnosis and treatment. Other disease categories
showed similar patterns of lower quality in the private sector. In
Nigeria, public providers were significantly more likely to use rapid
malaria diagnostics and to use the recommended combination
therapies than private providers [47].
Similar poor adherence to guidelines in prescription practices,
including subtherapeutic dosing, by private sector providers has
been associated with a rise in drug-resistant malaria in Nigeria
[47]. Parallel results were reported from Viet Nam [48]. In an
analysis of outcome data from 24 countries, children with diarrhea
were found to be less likely to receive appropriate oral rehydration
salts and more likely to receive unnecessary antibiotics when
seeing private providers than when seeing public providers [49].
However, a study of 119 private and ten public health clinics in
Uganda found that both private and public providers prescribed
antibiotics incorrectly (including not prescribing them when
indicated), and in this study public providers were worse in
adhering to national malaria treatment standards (14% versus
27%, p=0.002) [45].
Poor adherence to guidelines in prescription practices, including
prescribing subtherapeutic doses, failure to provide oral rehydra-
tion salts, and prescribing of unnecessary antibiotics were more
likely to occur among private than public providers [47–49],
although there were exceptions [45]. Higher rates of potentially
unnecessary procedures, particularly cesarean sections (C-sec-
Table 2. Systematic review inclusion criteria.
Aspect Minimum Criteria for Inclusion
Data collection in
facilities
If comparison between public and private programs, comparators were randomly selected, or population matched/adjacent.
Sample size For quantitative studies, must include .20 patients per facility or program described, or more than 100 persons if community-based
household surveys. If questionnaire-based, must include .50% response rate.
For qualitative studies, must include description of interviewees and systematic selection criteria.
Data description For quantitative studies, must include data selection criteria, population demographic description, data collection method, and statistical
analysis description.
For qualitative studies, study must include population selection results based on specified criteria, data collection approach, and data synthesis
strategy involving more than one author-reviewer if using a grounded-theory approach.
For household surveys, study must include census of households or random selection from list of available households.
For economics/cost-effectiveness studies, must specify data sources for costs and QALYs, specify model parameters and transition
probabilities, conform to gold standards for CEA analysis [113] and specify discounting rates and method of summing costs across specified
population.
Data presentation Data and tables should add up and be consistent.
Absolute numbers must be given, or denominators must be available for percentage results.
Exclude if obvious data errors; inquire from authors in case of suspected typos.
If statistical tests were performed, the tests need to be appropriate for the type of data being analyzed.
Bias No other important issues in design, conduct, or analysis that could introduce bias considered on an individual basis, e.g., amount of potential
bias if using different methods for collecting data between private and public providers.
No unusual events occurred during study that could introduce bias.
CEA, cost-effectiveness analysis; QALYs, quality-adjusted life years.
doi:10.1371/journal.pmed.1001244.t002
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One analysis of the Peruvian health system found significantly
higher rates of C-sections after the privatization of delivery. The
pre-reform rates in the private sector were already higher than the
WHO recommended rate of 10%–15%; after reform, the rate
exceeded 50%. The same has been found in South Africa, where
62% of women delivering in the private sector had C-sections,
compared with 18% in the public sector [51]. Studies in Mexico
suggested that fee-for-service payment structures (which are more
heavily present in private than in public care delivery settings)
incentivized increased C-sections [23].
Two cross-sectional studies documented a lack of drug
availability and service provision at public facilities. A semi-
structured questionnaire distributed to 24 health secretariats and
directors of 39 city hospitals and 26 referral and teaching hospitals
revealed that 76% of state facilities and 67% of city facilities lacked
Figure 2. Flow diagram of study selection.
doi:10.1371/journal.pmed.1001244.g002
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private sector facilities (though the exact percentage among such
private facilities was not evaluated) [52]. In Tanzania, a semi-
structured questionnaire distributed to 80 randomly selected
patients and 45 health facility personnel staff working in diabetic
clinics found that private facilities tend to stock more types of oral
hypoglycemic agents than public facilities [53]. However, studies
did not make clear whether the additional types of drugs were
related to better outcomes or were simply additional brands of
equivalent medication on hand.
Some studies of quality of care were performed in the private
sector without having a comparative public sector group. Two
studies in South Africa found that the majority of private general
practitioners were not aware of the recommended medications,
doses, or durations for treatment of sexually transmitted infections
[54,55]. Reviews in Nigeria and Laos reported similarly
widespread use of ineffective therapies for malaria in the private
sector [56,57]. Sexually transmitted disease management in
private clinics and drugs shops in Uganda revealed that 93% of
cases were not properly managed per national guidelines, and the
cure rate was 47% [58].
Dispensation of unnecessary medications and procedures was
also reported to be higher among private sector providers
according to four reports based on chart reviews. The most
Table 3. Characteristics of included studies.
Characteristic
South Asia,
East Asia, and
Pacific
Sub-Saharan
Africa Latin America Other
Multiple Continents/Not
Context-Specific Total
Study year range
1980–1989 0 0 1 0 0 1
1990–1999 2 5 2 1 2 12
2000–2009 29 23 8 5 13 78
2010–2011 3 4 2 0 2 11
Report type
Empirical research 29 21 5 4 0 59
Review/commentary 2 5 4 0 11 22
Meta-analysis/data synthesis 1 4 2 2 4 13
Case study 2 2 2 0 2 8
Primary study purpose (research
studies)
Describe or compare quality of
private and public services
18 11 3 6 4 42
Assess drug availability and affordability 1 4 1 0 2 8
Assess demand for, access to,
or utilization of services
13 14 9 0 11 47
Compare costs or efficiency of services 2 3 0 0 0 5
Facility types
Hospitals 1 1 2 1 0 5
Outpatient clinics 3 4 0 1 0 8
Pharmacies 1 1 2 0 0 4
Multiple types 24 18 8 2 11 63
Not specified 5 8 1 2 6 22
Service type
Promotive or preventive 3 3 1 1 1 9
Curative, rehabilitative, or palliative 20 15 5 3 4 47
All types 11 14 7 2 12 46
Disease category
CD 19 17 4 2 4 46
NCD 3 2 5 1 2 13
Both CD and NCD 12 13 4 3 11 43
Population age
Adults 7 12 6 2 2 29
Children 4 1 0 1 2 8
Both adults and children 23 19 7 3 13 65
CD, communicable disease; NCD, noncommunicable disease.
doi:10.1371/journal.pmed.1001244.t003
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treatment of diarrheal diseases and non-complicated acute
respiratory infections [32,49]. Reports from Africa and Laos
suggest ineffective and sometimes harmful pharmaceuticals are
being distributed in the private sector [56,57].
Surveys of patients’ perceptions of care quality were mixed.
While two survey-based studies suggested that patients perceived
higher quality among private practitioners, possibly due to
frequent prescribing of medications and more time spent with
patients [20,34], three interview-based studies suggested that
patients perceived public sector healthcare workers as more
competent [32,59,60].
Theme 3. Patient Outcomes
Public sector provision was associated with higher rates of
treatment success for tuberculosis and HIV [61–64] as well as
vaccination [65,66]. For example, in Pakistan, a matched cohort
study in Karachi found that public sector tuberculosis care resulted
in an 85% higher treatment success rate than private sector care
[63]. In Thailand, patients seeking care in private institutions had
significantly lower treatment success rates for tuberculosis, which
was attributed to a three to five times greater likelihood of being
prescribed non-WHO-recommended regimens than in the public
sector [61]. In South Korea, tuberculosis treatment success rates
were 51.8% in private clinics as opposed to 79.7% in public clinics,
with only 26.2% of patients in private clinics receiving the
recommended therapy, and over 40% receiving an inappropri-
ately short duration of therapy [62]. Similarly higher rates of
treatment failure were observed for private than public system
patients on antiretroviral therapy for HIV in Botswana [64]. In
India, an analysis of over 120,000 households, adjusted for
demographic and socioeconomic factors, found that children
receiving private health services were less likely to receive measles
vaccinations [65]. Similar findings were reported from Cambodia
[66].
Studies comparing pre- and post-privatization outcomes tended
to find worse health system performance associated with rapid and
extensive healthcare privatization initiatives. In Colombia, follow-
ing major privatization reforms in 1993, population vaccine
coverage declined for several diseases in the country, and
tuberculosis incidence rose significantly [67]. In Brazil, privatiza-
tion of fertility control services led to increased abortions,
sterilization, and improper use of oral contraceptives (obtained
without medical consultation), ultimately linked to higher mortal-
ity rates among young women [68]. However, a slower pace of
privatization of health care services did not appear to correlate
with a substantial worsening in patient outcomes among Latin
American countries [69].
Theme 4. Accountability, Transparency, and Regulation
Data on this theme tended to be unavailable from the private
sector. No papers were found to describe any systematic collection
of outcome data from entirely private sector sources. One recent
independent review of Ghana’s private sector referred to the
private sector as a ‘‘black box,’’ with a dearth of information on
delivery practices and outcomes [22]. Tuberculosis and malaria
case notification to the public health system was particularly poor
among private sector providers as compared to public providers in
a number of countries [28,48,70]. However, while national vital
statistics databases collected from public sector clinics and
hospitals were widely available, they varied considerably in quality
according to external assessments [22,71].
Public–private partnerships also lacked data. A systematic
review of data from public–private partnerships (including
arrangements among governments and private, for-profit contrac-
tors) found few reported data that were of sufficient quality to
assess the impact of partnership services and programs [72]. Poor
data availability was observed in another systematic collection
from several countries’ private–public partnerships for sexual and
reproductive health services. Most data available showed that after
brief training of health providers, provider responses to question-
naires improved in accuracy, but no assessments were made of
health outcomes [71]. An exception was a partnership in India
that demonstrated increased birth attendant coverage from 27%
to 53% over 7 mo among a cohort of 97,000 women [73].
Several reports observed significant public spending being used
to regulate the private sector in order to improve patient care
quality, particularly in African countries, and with limited
effectiveness [22,74–76]. The effectiveness of these regulations of
the private sector was found to vary, often depending on public
monitoring and enforcement [17,34,77]. Regulations to reduce the
sale of unnecessary breast milk substitutes by private drug shops in
Laos had limited impact until government inspectors visited sites
to ensure appropriate sales and provided sanctions for legal
violations [17]. In Indonesia, Kenya, Pakistan, and Bihar, clinical
education programs to improve distribution of oral rehydration
salts and reduce inappropriate antibiotic prescribing were found to
have a greater impact when patients also received education, and
when community healthcare workers were involved in monitoring,
than when education was given only to clinicians [17]. Reviews in
Zimbabwe and Tanzania identified anti-competitive practices and
sales of inappropriate drugs [75]; attempted regulations in
Zimbabwe were ineffective [76]. One review in Ghana indicated
that the key public agency in charge of such regulation was unable
to identify a large number of private providers in order to assess
accreditation and quality: 2,612 of 11,430 drug shops were
registered but had not received licenses [22]. A private–public
partnership in South Africa to educate providers about national
guidelines for sexually transmitted disease prevention and control
had no effect on practice [77]. In Egypt a comparative assessment
of clinical education programs found greater improvements in
public sector practices than private sector practices [34].
Theme 5. Fairness and Equity
Financial barriers to care, particularly user fees, were reported
to be prevalent in both private and public systems. A World Bank
study in Ghana concluded that there was no systematic evidence
indicating whether user fees in the public sector were different
than in the private sector [78]; however, the data presented
showed that out-of-pocket user fees for patients were highest for
private not-for-profit, lowest for public, and intermediate for
private self-financed providers [22]. Hence, the conclusions of the
report appear to be disputed by the data within the report.
As noted in the preceding sections, private sector health services
tend to cater more greatly to groups with higher income and fewer
medical needs (an illustration of the ‘‘inverse care law’’), resulting
in disparities in coverage [35,79–85], although findings varied in
several cases [86,87]. Some studies suggested there was a
systematic bias against indigent patients in terms of both quality
and access. Exclusion of poor patients by the private sector was
observed in South Africa [80] and Paraguay [81]. Poor patients
were as likely as wealthier patients to seek care from private
providers in Laos, but poorer patients received service from less
qualified providers, with limited-quality services (no exam or
advice, only medication dispensing) [35]. While most reports
described income-based stratification in access, one report
described stratification based on gender in addition to income. A
nationally representative, cross-sectional, cluster-sample survey of
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across Bangladesh observed that over 90% were taken to the
private sector. However, when patients arrived at private clinics,
children from higher income households and male children were
significantly more often (p,0.001) directed to a licensed provider
and treated with oral rehydration solution or an antibiotic than
female or poor children [85].
Several studies suggested that the process of privatizing existing
public services increased inequalities in the distribution of services.
Analyses of the Tanzanian and Chilean health systems found that
privatization led to many clinics being built in areas with less need,
whereas prior to privatization government clinics had opened in
underserved areas and made greater improvements in expanding
population coverage of health services [82–84]. Privatization in
China was statistically related to a rise in out-of-pocket expendi-
tures, such that by 2001, half of Chinese surveyed reported that
they had forgone health care in the previous year due to costs; out-
of-pocket expenses accounted for 58% of healthcare spending in
2002 compared with 20% in 1978 when privatization began. The
cost burdens of privatization related to an increase in disparities in
healthcare coverage and infant mortality between urban and rural
areas [79]. One survey-based study using Demographic Health
Survey data from 34 sub-Saharan African countries found that
privatization was associated with increased access, and reduced
disparities in access between rich and poor [86]. A second analysis
of the same dataset, however, found no change in inequality in use
of modern contraceptives with the expansion of the private sector
[87].
Private contracting and social franchises showed potential for
expanding private sector coverage to impoverished groups,
although conclusions are tentative because comparisons to the
public sector were unavailable. One World Bank study in
Cambodia reported improvements in healthcare coverage in poor
districts after contracting out services to private companies
specifically to increase coverage. When contracts explicitly
included targets for reaching the poor, contractors improved
health services for the most marginalized groups, although
comparison was not made to the results of a similar investment
in public sector services [88]. Several related World Bank
initiatives took the form of social franchises, in which private
providers pay a fee and are provided training, managerial
assistance, and certification in a provider network [20,89,90].
Several case studies of social franchises [20,89,90] found higher
care utilization among the lower socioeconomic groups of private
franchisers than of control private clinics for contraceptive use,
HIV counseling, antenatal care, and vaccination [17,91,92].
Theme 6. Efficiency
Several reports observed higher prescription drug costs in the
private sector for equivalent clinical diagnoses [33,36,53,67,93–
96]. In a survey study of prescription costs in India, costs were
higher for every class of visit in the private sector [33]. Two-thirds
of outpatients in the private sector, compared with one-third in the
public sector, received an injection for similar presentations, but
the study did not investigate what fraction was unnecessary [33].
Both generic and brand-name drugs were found to be higher in
price in the private sector [96]. Tanzanian private facilities
typically used more brand-name oral hypoglycemic agents, but
even generic medications were five times higher in price [53].
Similar findings were reported in India [96]. A study in
Bangladesh found that private sector healthcare prices in the
country—not just those associated with medications—have been
growing far above the inflation rate [36].
There is also evidence that the process of privatization is
associated with increased drug costs [36,53,67,93,94,96]. A study
of the Malaysian health system found that increasing privatization
of health services was associated with increased medicine prices
and decreased stability of prices [93]. Healthcare costs in
Colombia rose significantly following privatization reform in
1993, and 52% of capitation fees were spent on administration
[67]. Similar privatization in some parts of South Africa were
associated with a 13% to 32% cost increase in overall health
spending, without associated increases in coverage or indications
[94]; costs of prescriptions were significantly lower in the public
sector, likely due to generic substitution, prepackaging of
medications, and use of treatment protocols [95].
Higher drug costs are in part associated with disease compli-
cations attributable to delayed diagnosis or incorrect disease
management [97,98]. In Bolivia, seeking care in the private sector
was associated with longer delays in tuberculosis diagnosis and
greater costs [97,98]. It was estimated that in Mexico, Brazil, and
South Africa, unnecessary C-sections increased delivery-related
health costs in the private sector by at least 10-fold [23]. In
Bangladesh, private contracting of health services appeared to
increase costs related to complications and delays in service access
[36].
Several World Bank studies found significant fragmentation in
purchasing and distribution across and within the public and
private sectors, resulting in higher drug prices and redundant
treatments that increase overall healthcare costs [22,99]. The
absence of reliable distributors for pharmaceuticals in a study in
Ghana led to several intermediary groups being used to distribute
medications, increasing prices between 5% and 200% [22]. The
large number of small-scale hospitals and clinics in some sub-
Saharan African countries fragmented delivery, such that patient
diagnoses and treatment histories were unavailable between
institutions [22,99], often significantly delaying care, and resulting
in redundant tests and sometimes administration of incorrect
medication to patients. Several private primary care providers
reported difficulties referring their patients to public sector
secondary care facilities, as public facilities did not accept the
diagnoses made by the private providers and often required the
patient to restart the consultation process [99].
Competition between public and private delivery tended to
decrease drug prices. One large multilevel analysis of the content
and cost of 700 medication transactions observed in 14 private and
public settings in Mali revealed that private providers were more
likely to prescribe brand-name drugs, injectable drugs, and more
antibiotics; however, the availability of drugs in the public sector
decreased prices in the private sector [100].
Contracting of public healthcare services to private providers
has also been estimated by the World Bank to reduce costs of and
waiting times for contracted services [36,101], although the effects
of contracting differ markedly by the type of healthcare service and
across countries [17,102]. In Cambodia, contracted districts had
costs of $22.7 per person per year versus $26.4 among non-
contracted districts, although there were no tests of statistical
significance [36]. One highly cited secondary analysis reported this
outcome as a 17% savings resulting from contracting [101]. Peer-
reviewed studies of contracting in Zimbabwe and South Africa
found that costs were unchanged by contracting in South Africa
but were lower after contracting in Zimbabwe [17]. One review of
contracting experience in Madagascar and Senegal found that
large expenditure from public sector ministries was necessary to
manage and supervise private contracts, increasing overall costs in
those two countries by 13% and 17%, respectively [102].
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A few key findings reported in articles did not clearly fit into the
WHO health system themes, mainly involving recent reports of
complex ‘‘competitive dynamics’’ between private and public
health sectors. First, a ‘‘crowding out’’ effect appeared to occur
between private and public sector services for expanding delivery.
This process involved the transfer of public funds and personnel to
private sector development, followed by reductions in public sector
service budgets and staff availability. In Ghana, new private
services in urban middle- and upper-socioeconomic populations
were found to reduce revenues for public sector hospitals that also
provided care to poorer populations [22]. At times, however, the
process was a passive privatization: public sector funds were
increasingly allocated to private–public partnerships without
accompanying shifts in demand, so that the public sector’s
effective budget per patient was reduced. This dynamic was
observed in post-apartheid South Africa [103], as well as in
Uganda [104] and Brazil [105]. Public–private partnerships and
private contractors were often involved in such scenarios, but did
not typically disclose the data necessary to fully evaluate these
arrangements.
Public and private sector interactions also had implications for
delivery, staffing, and disease control. Interviews of Indian patients
suggested that several private practitioners who work in both
public and private sectors advised patients to visit their private
clinics or requested further payments in order to continue
providing care in the public clinic [106]. Doctors tended to
migrate towards private sector and urban jobs, depriving the
public sector and rural areas of physicians [107]. However, private
hospital systems often subsidize or provide healthcare technologies
to patients who cannot obtain these services from public hospitals.
For example, in Botswana, private hospitals often receive cancer
patients from public hospitals that are unable to provide radiation
oncology services [78]. In some cases, however, the services in
differing sectors undermined performance of one or both sectors.
Several studies found that poor reporting of diseases in the private
sector impeded public sector control of communicable diseases
[28,48,70].
Discussion
Our systematic review of comparative analyses of public and
private healthcare systems in low- and middle-income countries
found strengths and limitations in both sectors for each of six main
WHO health systems framework themes. Private sector healthcare
systems tended to lack published data by which to evaluate their
performance, had greater risks of low-quality care, and served
higher socio-economic groups, whereas the public sector tended to
be less responsive to patients and lacked availability of supplies.
Contrary to prevailing assumptions, the private sector appeared to
have lower efficiency than the public sector, resulting from higher
drug costs, perverse incentives for unnecessary testing and
treatment, greater risks of complications, and weak regulation.
Both public and private sector systems had poor accountability
and transparency. Within all WHO health system themes, study
findings varied considerably across countries and by the methods
employed.
The review has several limitations, which reflect the existing
data and literature purporting to compare the healthcare
performance of public and private sectors. First, existing studies
have focused on isolated topics where data are more abundant,
and as a result have overlooked important dimensions of health
sector performance. To address this limitation, we drew on a
broader range of data, including reports from non-governmental
organizations and international agencies like the World Bank. This
step was particularly important for acquiring data from the private
sector, since such data are relatively unavailable in the peer-
reviewed academic literature. Thus, some studies included were
not peer-reviewed. Our review involved a detailed analysis of
methodological criteria for these studies to ensure they met similar
standards of data analysis and reporting as peer-reviewed research.
Second, although it was not possible to perform a quantitative
meta-analysis because of variations in coding and outcomes, we
were able to identify unsubstantiated claims in several cases, which
appeared more prominent among non-peer reviewed sources. For
example, the World Bank has made strong claims that investing in
public–private partnerships will improve efficiency and effective-
ness in the health sector [108], yet several of its publications
revealed that these assertions were either unsupported by data or
the data was not provided in sufficient detail to pass minimal
inclusion criteria required for this review [20,78]. Efforts are
needed to address potential conflicts of interest of such agencies
and their implications for research and data reporting, particularly
as their analyses are often very highly cited in the academic
literature on health system assessment and performance.
Third, our reliance of the WHO health system themes enabled
the analysis to address systematically and comprehensively the
existing research on public and private sectors. However, a
limitation of the thematic framework, for example, is that several
elements of the patient experience in healthcare settings, such as
waiting times, are not systematically cataloged in current
assessments. This implies that future research in the area should
include a focus on how experiential aspects of care are relevant to
healthcare seeking and outcomes (such as the likelihood of follow-
up among patients requiring return visits) for differently structured
care environments. Fourth, the review identified mixed results in
several cases and was unable to account for a range of potential
modifying factors, partly as a limitation of the broad WHO health
system components that do not incorporate contextual factors. For
example, treatment of infectious diseases in public settings may be
more efficient than in private settings because of higher volume,
and greater use of systematized protocols due to that higher
volume. Such differences limit the ability of existing work to
compare fairly the public and private sector for differing disease
categories and in differing social and economic contexts of
healthcare delivery.
Although it was not the focus of our research, we observed that
some of our findings in low- and middle-income countries
mirrored existing evidence from high-income countries. For
example, the lack of data from private sector groups was similar
to the situation in the UK, where the privately run Independent
Sector Treatment Centres was unable to provide healthcare
performance data when required [109]. However, our evidence
also indicates that contextual factors modify the relationships we
have observed, so that it is not straightforward to transpose health
system evidence from high-income countries to low- and middle-
income countries. Importantly, we observed that regulatory
conditions interact with the effectiveness of public and private
sector provision, but in low- and middle-income countries
regulatory capacity is much weaker. As one example, the reviewed
data suggest that systems that incentivize more procedures (rather
than better outcomes) tend to lead to inefficiencies and poorer
health outcomes. One extensively studied alternative system in
high-income countries is pay-for-performance remuneration sys-
tems. It remains unclear what effects such programs may have in
low- and middle-income countries as compared to high-income
countries.
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policy. Future research is needed to address several important
methodological limitations of existing studies. Many analyses were
excluded from the review because they lacked a systematic
approach to cataloging health system quality. Ideally, analyses
should be comparative and should include a ‘‘counterfactual’’ in
order to make causal claims about the effects of the particular
benefits of providing services in one sector or the other. For
example, social franchising to engage private providers in an
organized regulatory system, which has been extensively piloted,
has yet to be analyzed over the long term using outcome data and
a comparison with commensurate investment in public sector
development [88]. Studies also need to specify carefully the
definition of the private and public sectors. When the private
sector included unlicensed physicians, it was found to provide the
majority of coverage for low-income groups, but when only
licensed providers were included, the public sector was found to be
the main source of healthcare provision in low- and middle-
income countries. While some commentators report a higher
number of absolute healthcare workers in the private sector, and a
higher number of visits among the population to the private sector,
these observation may be artifacts of improperly coding a large
portion of private ‘‘providers’’ who are not actually qualified
healthcare personnel, but rather drug store salespeople [1,5]. Most
studies fail to capture the full scope of effects of reforms on the
healthcare system, focusing on an isolated health system compo-
nent. A reform may enhance public sector performance but
compromise the market in the private sector, or vice versa.
Standards may need to be developed for health system research for
identifying what is ‘‘safe’’ and ‘‘effective’’ overall for patients across
socioeconomic strata, just as we do for pharmaceutical safety and
efficacy.
Some authors have highlighted the lack of regulatory infra-
structure available in low- and middle-income countries to
monitor the performance of private healthcare contractors [110].
Despite the lack of data about private sector performance, recent
initiatives by the World Bank’s International Finance Committee
are underwriting the expansion of private sector services among
low- and middle-income countries. For example, in sub-Saharan
Africa, the International Finance Committee has created a private
equity fund to make 30 long-term investments in private health
companies. These conflicts of interest pose a potential threat to the
validity of World Bank–sponsored studies and raise the need for
independent scrutiny.
Our review indicates that current data do not support claims
that the private sector has been more efficient, accountable, or
medically effective than the public sector [8]. The review also
identifies several areas of focus for quality improvement. In the
private sector, benefits may accrue from enhancing medical
knowledge for appropriate diagnosis and disease management,
drawing on specific quality improvement programs for continuing
medical education that may serve as models [17]. It is also
important to address conflicts of interest from physician-induced
demand, particularly when prescribers are also drug store owners.
Regulation and consumer education have been more successful
than a reliance on clinical education alone in Pakistan and Bihar
[17]. In the public sector, quality improvement may need to
address incentives to perform at high standards among providers
who may not feel threatened by a lack of business in the manner
that private practitioners do. One proposed approach is to link
provider compensation with results from patient outcomes,
weighted by baseline disease risk in the patient population [111].
More generally, policy research needs to determine how targeted
interventions might address these core weaknesses among both
private and public delivery environments, including the lack of
disclosure of outcome and performance data; as a measure of
accountability, public transparency can be considered a vital sign
of system performance (particularly for those systems receiving
public subsidies; [112]). While there is no clear definition of a
‘‘basic minimum dataset’’ for countries to capture health sector
performance, we did notice several common themes in our data
review. In many of the countries studied, surveillance of disease
treatment outcomes among adults, and particularly noncommu-
nicable disease, was found to be limited. Furthermore, we found
further data gaps in health system performance around the issues
of waiting times, financing changes (e.g., to further characterize
the ‘‘competitive dynamics’’ we described), and outcomes of
quality improvement efforts within each sector.
A critical challenge in years to come is how to address
competitive dynamics between private and public realms, so that
public sector facilities are not stripped of resources that are given
to the private sector as subsidies, and so that the ability of public
clinics and hospitals to retain skilled healthcare workers is not
compromised, especially as both types of systems attempt to
coexist in the healthcare delivery environment of low- and middle-
income countries. These findings are consistent with earlier
findings of an ‘‘infrastructure inequality trap’’ in some countries
[103], in which government funding is increasingly attracted
towards private hospitals and away from the public sector
hospitals. This occurs when private patients can afford to pay
for greater infrastructure at private hospitals. Those hospitals then
report greater ‘‘absorptive capacity’’ for future funds, and higher
numbers of healthcare personnel, thereby attracting more funding
from government institutions, shifting budgets away from public
sector facilities that struggle to maintain human and physical
infrastructure. Furthermore, we found evidence that many public–
private initiatives involve public sector funding being dedicated to
monitoring and preventing corruption in the private sector.
Overall, the data describing the performance of public and
private systems remains highly limited and poor in quality,
suggesting that further investigations should more systematically
make data available to track the performance of both public and
private care systems before further judgments are made concern-
ing their relative merits and risks.
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Background. Health care can be provided through public
and private providers. Public health care is usually provided
by the government through national healthcare systems.
Private health care can be provided through ‘‘for profit’’
hospitals and self-employed practitioners, and ‘‘not for
profit’’ non-government providers, including faith-based
organizations.
There is considerable ideological debate around whether
low- and middle-income countries should strengthen public
versus private healthcare services, but in reality, most low-
and middle-income countries use both types of healthcare
provision. Recently, as the global economic recession has put
major constraints on government budgets—the major
funding source for healthcare expenditures in most coun-
tries—disputes between the proponents of private and
public systems have escalated, further fuelled by the
recommendation of International Monetary Fund (an inter-
national finance institution) that countries increase the scope
of private sector provision in health care as part of loan
conditions to reduce government debt. However, critics of
the private health sector believe that public healthcare
provision is of most benefit to poor people and is the only
way to achieve universal and equitable access to health care.
Why Was This Study Done? Both sides of the public
versus private healthcare debate draw on selected case
reports to defend their viewpoints, but there is a widely held
view that the private health system is more efficient than the
public health system. Therefore, in order to inform policy,
there is an urgent need for robust evidence to evaluate the
quality and effectiveness of the health care provided
through both systems. In this study, the authors reviewed
all of the evidence in a systematic way to evaluate available
data on public and private sector performance.
What Did the Researchers Do and Find? The researchers
used eight databases and a comprehensive key word search
to identify and review appropriate published data and
studies of private and public sector performance in low- and
middle-income countries. They assessed selected studies
against the World Health Organization’s six essential themes
of health systems—accessibility and responsiveness; quality;
outcomes; accountability, transparency, and regulation;
fairness and equity; and efficiency—and conducted a
narrative review of each theme.
Out of the 102 relevant studies included in their comparative
analysis, 59 studies were research studies and 13 involved
meta-analysis, with the rest involving case reports or reviews.
The researchers found that study findings varied consider-
ably across countries studied (one-third of studies were
conducted in Africa and a third in Southeast Asia) and by the
methods used.
Financial barriers to care (such as user fees) were reported for
both public and private systems. Although studies report
that patients in the private sector experience better
timeliness and hospitality, studies suggest that providers in
the private sector more frequently violate accepted medical
standards and have lower reported efficiency.
What Do These Findings Mean? This systematic review
did not support previous views that private sector delivery of
health care in low- and middle-income settings is more
efficient, accountable, or effective than public sector
delivery. Each system has its strengths and weaknesses,
but importantly, in both sectors, there were financial barriers
to care, and each had poor accountability and transparency.
This systematic review highlights a limited and poor-quality
evidence base regarding the comparative performance of
the two systems.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001244.
N A previous PLoS Medicine study examined the outpatient
care provided by the public and private sector in low-
income countries
N The WHO website provides more information on
healthcare systems
N The World Bank website provides information on health
system financing
N Oxfam provides an argument against increased private
health care in poor countries
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